Top

Published in:

01-07-2016 | Original Paper

Anti-dormant mycobacterial activity and target molecule of melophlins, tetramic acid derivatives isolated from a marine sponge of Melophlus sp.

Authors: Masayoshi Arai, Yoshi Yamano, Kentaro Kamiya, Andi Setiawan, Motomasa Kobayashi

Published in: Journal of Natural Medicines | Issue 3/2016

Abstract

Tuberculosis (TB), caused by Mycobacterium tuberculosis infection, is a major world health problem that is responsible for the deaths of 1.5 million people each year. In addition, the requirement for long-term therapy to cure TB complicates treatment of the disease. One of the major reasons for the extended chemotherapeutic regimens and wide epidemicity of TB is that M. tuberculosis has the ability to persist in a dormant state. We therefore established a new screening system to search for substances with activity against dormant mycobacteria using M. smegmatis and M. bovis BCG cultivated in medium containing propionate as sole carbon source to induce dormancy. Subsequently, melophlins A (1), G (2), H (3), and I (4), tetramic acid derivatives, were re-discovered from the Indonesian marine sponge of Melophlus sp. as anti-dormant mycobacterial substances. Moreover, target analysis of melophlin A indicated that it targeted the BCG1083 protein of putative exopolyphosphatase and the BCG1321c protein of diadenosine 5′,5‴-P¹,P⁴-tetraphosphate phosphorylase.

Idemyor V (2007) HIV and tuberculosis coinfection: inextricably linked liaison. J Natl Med Assoc 99:1414–1419PubMedPubMedCentral

Global Tuberculosis report 2015 World Health Organization: Geneva, Switzerland. http://www.who.int/tb/publications/global_report/en/. Accessed on 15 Feb 2016

Arai M, Sobou M, Vilcheze C, Baughn A, Hashizume H, Pruksakorn P, Ishida S, Matsumoto M, Jacobs WR Jr, Kobayashi M (2008) Halicyclamine A, a marine spongean alkaloid as a lead for anti-tuberculosis agent. Bioorg Med Chem 16:6732–6736CrossRefPubMed

Arai M, Ishida S, Setiawan A, Kobayashi M (2009) Haliclonacyclamines, tetracyclic alkylpiperidine alkaloids, as anti-dormant mycobacterial substances from a marine sponge of Haliclona sp. Chem Pharm Bull 57:1136–1138CrossRefPubMed

Pruksakorn P, Arai M, Kotoku N, Vilcheze C, Baughn AD, Moodley P, Jacobs WR Jr, Kobayashi M (2010) Trichoderins, novel aminolipopeptides from a marine sponge-derived Trichoderma sp., are active against dormant mycobacteria. Bioorg Med Chem Lett 20:3658–3663CrossRefPubMed

Yamano Y, Arai M, Kobayashi M (2012) Neamphamide B, new cyclic depsipeptide, as an anti-dormant mycobacterial substance from a Japanese marine sponge of Neamphius sp. Bioorg Med Chem Lett 22:4877–4881CrossRefPubMed

Arai M, Han C, Yamano Y, Setiawan A, Kobayashi M (2014) Aaptamines, marine spongean alkaloids, as anti-dormant mycobacterial substances. J Nat Med 68:372–376CrossRefPubMed

Arai M, Yamano Y, Setiawan A, Kobayashi M (2014) Identification of the target protein of agelasine D, a marine sponge diterpene alkaloid, as an anti-dormant mycobacterial substance. ChemBioChem 15:117–123CrossRefPubMed

Sassetti CM, Rubin EJ (2003) Genetic requirements for mycobacterial survival during infection. Proc Natl Acad Sci USA 100:12989–12994CrossRefPubMedPubMedCentral

10.

McKinney JD, Bentrup KH, Muñoz-Elías EJ, Miczak A, Chen B, Chan WT, Swenson D, Sacchettini JC, Jacobs WR Jr, Russell DG (2000) Persistence of Mycobacterium tuberculosis in macrophages and mice requires the glyoxylate shunt enzyme isocitrate lyase. Nature 406:735–738CrossRefPubMed

11.

Muñoz-Elías EJ, Upton AM, Cherian J, McKinney JD (2006) Role of the methylcitrate cycle in Mycobacterium tuberculosis metabolism, intracellular growth, and virulence. Mol Microbiol 60:1109–1122CrossRefPubMed

12.

Aoki S, Higuchi K, Ye Y, Satari R, Kobayashi M (2000) Melophlins A and B, novel tetramic acids reversing the phenotype of ras-transformed cells, from the marine sponge Melophlus sarassinorum. Tetrahedron 56:1833–1836CrossRef

13.

Wang CY, Wang BG, Wiryowidagdo S, Wray V, Soest RV, Steube KG, Guan HS, Proksch P, Ebel R (2003) Melophlins C-O, thirteen novel tetramic acids from the marine sponge Melophlus sarassinorum. J Nat Prod 66:51–56CrossRefPubMed

14.

Xu J, Hasegawa M, Harada K, Kobayashi H, Nagai H, Namikoshi M (2006) Melophlins P, Q, R, and S: four new tetramic acid derivatives, from two Palauan marine sponges of the genus Melophlus. Chem Pharm Bull 54:852–854CrossRefPubMed

15.

Knoth T, Warburg K, Katzka C, Rai A, Wolf A, Brockmeyer A, Janning P, Ruebold TF, Eschenburg S, Manstein DJ, Hübel K, Kaiser M, Waldmann H (2009) The ras pathway modulator melophlin A targets dynamins. Angew Chem Int Ed 48:7240–7245CrossRef

16.

Arai M, Liu L, Fujimoto T, Setiawan A, Kobayashi M (2011) DedA protein relates to action-mechanism of halicyclamine A, a marine spongean macrocyclic alkaloid, as an anti-dormant mycobacterial substance. Mar Drugs 9:984–993CrossRefPubMedPubMedCentral

17.

Pruksakorn P, Arai M, Liu L, Moodley P, Jacobs WR Jr, Kobayashi M (2011) Action-mechanism of trichoderin A, an anti-dormant mycobacterial aminolipopeptide from marine sponge-derived Trichoderma sp. Biol Pharm Bull 34:1287–1290CrossRefPubMed

18.

Balasubramanian V, Pavelka MS Jr, Bardarov SS, Martin J, Weisbrod TR, McAdam RA, Bloom BR, Jacobs WR Jr (1996) Allelic exchange in Mycobacterium tuberculosis with long linear recombination substrates. J Bacteriol 178:273–279PubMedPubMedCentral

19.

Wayne LG, Sohaskey CD (2001) Nonreplicating persistence of Mycobacterium tuberculosis. Annu Rev Microbiol 55:139–163CrossRefPubMed

20.

Lim A, Eleuterio M, Hutter B, Murugasu-Oei B, Dick T (1999) Oxygen depletion-induced dormancy in Mycobacterium bovis BCG. J Bacteriol 181:2252–2256PubMedPubMedCentral

21.

Dick T, Lee BH, Murugasu-Oei B (1998) Oxygen depletion induced dormancy in Mycobacterium smegmatis. FEMS Microbiol Lett 163:159–164CrossRefPubMed

22.

Wayne LG, Hayes LG (1996) An in vitro model for sequential study of shiftdown of Mycobacterium tuberculosis through two stages of nonreplicating persistence. Infect Immun 64:2062–2069PubMedPubMedCentral

23.

Sassetti CM, Boyd DH, Rubin EJ (2003) Genes required for mycobacterial growth defined by high density mutagenesis. Mol Microbiol 48:77–84CrossRefPubMed

24.

Chuang YM, Bandyopadhyay N, Rifat D, Rubin H, Bader JS, Karakousis PC (2015) Deficiency of the novel exopolyphosphatase Rv1026/PPX2 leads to metabolic downshift and altered cell wall permeability in Mycobacterium tuberculosis. mBio 6:e02428CrossRefPubMedPubMedCentral

25.

Brenner C (2002) Hint, Fhit, and GalT: function, structure, evolution, and mechanism of three branches of the histidine triad superfamily of nucleotide hydrolases and transferases. Biochemistry 41:9003–9014CrossRefPubMedPubMedCentral

26.

Mori S, Shibayama K, Wachino J, Arakawa Y (2010) Purification and molecular characterization of a novel diadenosine 5′,5‴-P¹,P⁴-tetraphosphate phosphorylase from Mycobacterium tuberculosis H37Rv. Protein Expr Purif 69:99–105CrossRefPubMed

27.

Farr SB, Arnosti DN, Chamberlin MJ, Ames BN (1989) An apaH mutation causes AppppA to accumulate and affects motility and catabolite repression in Escherichia coli. Proc Natl Acad Sci USA 86:5010–5014CrossRefPubMedPubMedCentral

28.

Ismail TM, Hart CA, McLennan AG (2003) Regulation of dinucleoside polyphosphate pools by the YgdP and ApaH hydrolases is essential for the ability of Salmonella enterica serovar Typhimurium to invade cultured mammalian cells. J Biol Chem 278:32602–32607CrossRefPubMed

Title: Anti-dormant mycobacterial activity and target molecule of melophlins, tetramic acid derivatives isolated from a marine sponge of Melophlus sp.
Authors: Masayoshi Arai
Yoshi Yamano
Kentaro Kamiya
Andi Setiawan
Motomasa Kobayashi
Publication date: 01-07-2016
Publisher: Springer Japan
Published in: Journal of Natural Medicines / Issue 3/2016
Print ISSN: 1340-3443
Electronic ISSN: 1861-0293
DOI: https://doi.org/10.1007/s11418-016-1005-1

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Anti-dormant mycobacterial activity and target molecule of melophlins, tetramic acid derivatives isolated from a marine sponge of Melophlus sp.

Abstract

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 3/2016

Potency of extracts from selected Egyptian plants as inducers of the Nrf2-dependent chemopreventive enzyme NQO1

Longgu (Fossilia Ossis Mastodi) alters the profiles of organic and inorganic components in Keishikaryukotsuboreito

Anti-inflammatory effects of alpinone 3-acetate from Alpinia japonica seeds

Antithrombosis activity of protocatechuic and shikimic acids from functional plant Pinus densiflora Sieb. et Zucc needles

Chemical structures of constituents from the whole plant of Bacopa monniera

Lucidumol C, a new cytotoxic lanostanoid triterpene from Ganoderma lingzhi against human cancer cells